NCT03034187Recruiting
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
Radiation Induced Toxicity in Prostate Cancer
Source: ClinicalTrials.gov · Last updated 18 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 27 Sept 2016
- Start date
- 1 Apr 1999
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- University Medical Center Groningen
- Diseases
- Prostate cancer
- NCT number
- NCT03034187
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Apr 1999 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who are not willing to fill in toxicity and QOL-questionnarys Patients who will not get RT Non-curative or palliative treated patients (with bone mestasis) Non-prostate cancer-patients
Who the study is looking for
- All curative treated patients with prostatecancer( with positive lymph nodes)
- All patients who will be treated with RT( including post-operative, adjuvant treatments)
- Are willing to fill in toxicity and QOL-questionnarys (QLQ-PR25 en de QLQ-C30)
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Groningen Coordinator of this site? Confirm its status | Groningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.